(Q40083406)

17 September 2017

1 reference

title

Thymoxamine hydrochloride: an alpha-adrenergic blocker (English)

1 reference

17 September 2017

Thymoxamine hydrochloride: An alpha-adrenergic blocker (English)

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

author name string

M. Wand

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6108620

6 August 2023

W. M. Grant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6108620

6 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6108620

6 August 2023

publication date

1 September 1980

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0039625780901502?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

https://api.elsevier.com/content/article/PII:0039625780901502?httpAccept=text/plain

6 August 2023

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

published in

Survey of Ophthalmology

1 reference

17 September 2017

volume

25

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

75-84

1 reference

Effect of pilocarpine in counteracting mydriasis

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Effect of thymoxamine on circulation in skin flaps and in denervated skin

6 August 2023

2

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The cause of irreversible mydriasis following keratoplasty in keratoconus: a preliminary report

6 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Antagonism of the response of human isolated arteries to noradrenaline

6 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine

6 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Keratoconus, keratoplasty and iris atrophy

6 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The Use and Abuse of Vasodilator Drugs

6 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

Thymoxamine (Opilon)

11

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Pigmentary dispersion and glaucoma. A new theory

6 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Long-term trial of local guanethidine in treatment of eye signs of thyroid dysfunction and idiopathic lid retraction

6 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The Use of Thymoxamine in Eyelid Retraction

6 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The nature of the adrenergic receptors of the trachea of the guinea-pig

6 August 2023

20

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Thymoxamine in chilblains

6 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

On the treatment of vascular insufficiencies of the labyrinth with thymoxamine.

6 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Mydriatic Effect of Phenylephrine Hydrochloride

6 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Thymoxamine therapy for angle-closure glaucoma.

6 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Studies of thyroid and sympathetic nervous system interrelationships. I. The blepharoptosis of myxedema

6 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

Mechanics of pupil block

28

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

Safe mydriasis

29

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Haemodynamic Action of Thymoxamine (An Alpha-adrenergic Blocking Agent) in Occlusive Peripheral Arterial Disease

6 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

Drug therapy of glaucoma

33

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Alpha-adrenergic receptor blockade in the treatment of angle-closure glaucoma

6 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Mydriasis and increased intraocular pressure. I. Pupillographic studies

6 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Mydriasis and increased intraocular pressure. II. Iris fluorescein studies

6 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Mydriatic drugs for routine fundal inspection. A reappraisal

6 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Adrenergic blockade and the eye signs of thyrotoxicosis

6 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Action of thymoxamine on mydriasis induced by levodopa and dopamine

6 August 2023

42

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The effects of thymoxamine on anterior chamber depth in human eyes

6 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Local application of thymoxamine in peripheral vascular disease

6 August 2023

44

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Alpha receptor blockade by thymoxamine in the human eye

6 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

FIXED, DILATED PUPIL, IRIS ATROPHY AND SECONDARY GLAUCOMA

6 August 2023

46

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Fixed pupil following keratoplasty. Evaluation of six cases

6 August 2023

48

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The adrenergic receptors of the intraocular muscles of the human eye

6 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Thymoxamine hydrochloride: effects on the facility of outflow and intraocular pressure

6 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

Thymoxamine test. Differentiating angle-closure glaucoma form open-angle glaucoma with narrow angles

6 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

The Effects of Miotics On Anterior-Chamber Depth

6 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0039-6257(80)90150-2

6 August 2023

Identifiers

1 reference

17 September 2017

1 reference